| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |